BioSenicREGULATED INFORMATIONFollowing the in-principle agreement reached with its main creditors in the context of ongoing equity raise process, the focus...
Quarter
HOUSTON, July 17, 2023 /PRNewswire/ -- Stellus Funds Expenditure Company (the "Company") (NYSE: SCM) announced that its Board of Administrators...
Advanced portfolio transformation: Total investment income increased 40% to $1.7 million in the fourth quarter; Full year 2022 grew 41%...